Continuity of care between dyslipidemia patients and multiple providers: A cohort study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300745 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Eunyoung Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea. Hauptthemen laut MEDLINE: Dyslipidemias, Continuity of Patient Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Objective
This study aimed to investigate the impacts of continuity of care (COC) between patients and multiple providers, i.e., doctors and community pharmacists, on clinical and economic outcomes.
Methods
This is a retrospective cohort study and analyzed Korean national claims data for ambulatory care setting between 2007 and 2018. Patients with dyslipidemia newly diagnosed in 2008 were identified. COC between providers and patients was computed using the continuity of care index (COCI). Based on COCIs, the study patients were allocated to four groups: H M /H P , H M /L P , L M /H P , and L M /L P . Each symbol represents H for high, L for low, M for doctor, and P for pharmacist. The primary study outcome was the incidence of atherosclerotic cardiovascular disease (ASCVD).
Results
126,710 patients were included. Percentages of patients in the four study groups were as follows: H M /H P 35%, H M /L P 19%, L M /H P 12%, and L M /L P 34%. During the seven-year outcome period, 8,337 patients (6.6%) developed an ASCVD, and percentages in the study groups were as follows; H M /H P 6.2%, H M /L P 6.3%, L M /H P 6.8%, and L M /L P 7.1%. After adjusting for confounding covariates, only the L M /L P group had a significantly higher risk of ASCVD than the reference group, H M /H P (aHR = 1.16 [95% confidence interval = 1.10~1.22]). The risk of inappropriate medication adherence gradually increased 1.03-fold in the H M /L P group, 1.67-fold in the L M /H P , and 2.26-fold in the L M /L P group versus the H M /H P group after adjusting for covariates. Disease-related costs were lower in the H M /H P and L M /H P groups.
Conclusions
The study shows that patients with high relational care continuity with doctors and pharmacists achieved better clinical results and utilized health care less, resulting in reduced expenses. Further exploration for the group that exhibits an ongoing relationship solely with pharmacists is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
- Department of Pharmacy, Ulsan University Hospital, Ulsan, Republic of Korea.
- Department of Statistics and Probability, Michigan State University, East Lansing, MI, United States of America.
- College of Pharmacy, Ajou University, Suwon, Republic of Korea.
- Department of Informational Statistics, Andong National University, Andong, Republic of Korea.
- Department of Health Sciences, University of York, York, United Kingdom.
ORCID-Profile: Eunyoung Choi, Juhee Lee, Iyn-Hyang Lee
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, E., Lee, J., Choo, E., Jang, E. J., & Lee, I. H. (2024). Continuity of care between dyslipidemia patients and multiple providers: A cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0300745
Vancouver
Choi E, Lee J, Choo E, Jang EJ, Lee IH. Continuity of care between dyslipidemia patients and multiple providers: A cohort study. PLOS ONE. 2024. doi:10.1371/journal.pone.0300745
BibTeX
@article{Choi2024,
author = {Choi, Eunyoung and Lee, Juhee and Choo, Eunjung and Jang, Eun Jin and Lee, Iyn-Hyang},
title = {Continuity of care between dyslipidemia patients and multiple providers: A cohort study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300745}
}
EUVIMED